168 results
8-K
EX-99.1
PRPH
ProPhase Labs Inc
15 Mar 24
Nebula Genomics secures major international B2B deal – Additional significant B2B deals in final stages
8:00am
major long-term international agreement that, if signed, could represent an initial $10-$20 million in annual revenues. Additional significant agreements … Esophageal Cancer Test, our ability to enter into new domestic and international long-term contracts for our Nebula Genomics business and the financial
8-K
EX-99.1
PRPH
ProPhase Labs Inc
9 Nov 23
ProPhase Labs Announces Financial Results
8:00am
potential in both the short term and long term while absorbing minimal Adjusted EBITDA losses and maintaining a healthy net working capital balance … significant net profits in industries that have long term growth prospects and believes that all currently anticipated development activities can be funded
8-K
EX-99.1
PRPH
ProPhase Labs Inc
10 Aug 23
ProPhase Labs Announces Financial Results
8:00am
approximately $40 million in sequencing revenues annually at current revenues per test.
Currently negotiating multiple long-term volume commitments
8-K
EX-99.1
uuhwzq6d
26 Jul 22
ProPhase Labs Announces New $6 Million Stock Repurchase Plan
8:15am
8-K
EX-99.1
k60rva3nzs9lw6wc
13 May 22
ProPhase Labs Announces Record First Quarter 2022 Financial Results
10:07am
8-K
EX-10.1
mr0l 8n9w8to
29 Dec 21
Entry into a Material Definitive Agreement
4:10pm
8-K
EX-99.1
k7ran 6i0
16 Aug 21
ProPhase Labs Acquires Whole Genome Sequencing Company, Nebula Genomics
4:49pm
8-K
EX-99.1
t0m3c4fbe5iib2nz
13 Aug 21
Company Provides Update on Significant Resurgence in Covid testing and Additional Insights into Previously Announced Nebula Genomics Acquisition
8:14am